CAS 72856-73-6

2-Methoxy-4-(methylthio)benzoic acid

Description:

2-Methoxy-4-(methylthio)benzoic acid, with the CAS number 72856-73-6, is an organic compound that belongs to the class of benzoic acids. It features a methoxy group (-OCH3) and a methylthio group (-S-CH3) attached to a benzoic acid structure, which contributes to its unique chemical properties. This compound is typically characterized by its aromatic nature, which imparts stability and influences its reactivity. The presence of the methoxy group enhances its solubility in organic solvents, while the methylthio group can affect its electronic properties and reactivity in various chemical reactions. 2-Methoxy-4-(methylthio)benzoic acid may exhibit biological activity, making it of interest in pharmaceutical research. Its melting point, boiling point, and solubility characteristics can vary based on environmental conditions and purity. As with many organic compounds, it should be handled with care, following appropriate safety protocols to mitigate any potential hazards associated with its use.

Formula: C₉H₁₀O₃S

InChI: InChI=1S/C9H10O3S/c1-12-8-5-6(13-2)3-4-7(8)9(10)11/h3-5H,1-2H3,(H,10,11)

InChI key: InChIKey=UOPCPHJGGRTYNC-UHFFFAOYSA-N

SMILES: O(C)C1=C(C(O)=O)C=CC(SC)=C1

Synonyms:

• 2-Methoxy-4-(methylmercapto)benzoic acid
• 2-Methoxy-4-(methylthio)benzoic acid
• 2-Methoxy-4-(methylsulfanyl)benzoic acid
• Benzoic acid, 2-methoxy-4-(methylthio)-

2-Methoxy-4-(methylthio)benzoic acid

CAS: 72856-73-6

2-Methoxy-4-(methylthio)benzoic acid

Purity: 97%

Molecular weight: 198.24g/mol

Ref: 54-OR1056960

2-Methoxy-4-(methylsulfanyl)benzoic acid

CAS: 72856-73-6

2-Methoxy-4-(methylsulfanyl)benzoic acid is a thiazolopyridine prodrug that is converted to its active form, 2-methoxy-4-(methylsulfanyl)benzoyl chloride (MMBC), by esterases. MMBC inhibits the replication of both influenza A and B viruses in cell culture, with an IC50 of 0.5 μM. MMBC also has an inotropic effect on isolated rat cardiomyocytes, which may be due to inhibition of the virus-mediated inhibition of cardiac myosin ATPase activity. The pharmacokinetic properties of MMBC are determined experimentally by administering the drug orally to rats and measuring its concentration in serum. These data show that MMBC has a low oral bioavailability and a short elimination half-life.

Formula: C₉H₁₀O₃S

Purity: Min. 95%

Molecular weight: 198.24 g/mol

Ref: 3D-XCA85673